Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 46Neoplasms 34Breast Neoplasms 34Melanoma 26Neoplasm Metastasis 24Leukemia, Myeloid, Acute 21Colorectal Neoplasms 20Prostatic Neoplasms 19Lung Neoplasms 17Multiple Myeloma 16Ovarian Neoplasms 14Recurrence 13Myelodysplastic Syndromes 13Lymphoma, Non-Hodgkin 13Squamous Cell Carcinoma of Head and Neck 12Carcinoma, Renal Cell 12Uterine Cervical Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Hepatocellular 11Urinary Bladder Neoplasms 10Pancreatic Neoplasms 10Glioblastoma 10Brain Neoplasms 10Stomach Neoplasms 8Head and Neck Neoplasms 8Triple Negative Breast Neoplasms 7Rectal Neoplasms 7Lymphoma, Follicular 7Lymphoma 7Hodgkin Disease 7

Interventions

obeticholic acid 1Specimen Handling 1Endoscopy, Gastrointestinal 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Attenuated familial adenomatous polyposis × 90 days × Clear all
NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡